Wako, Japan

Yasuharu Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: The University of Tokyo. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuharu Sakamoto. Retrieved from https://idiyas.com/inventor/yasuharu-sakamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuharu Sakamoto: Innovator in Depression Treatment

Introduction

Yasuharu Sakamoto is a notable inventor based in Wako, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. His innovative approach has led to the development of a unique treatment agent that has the potential to improve the lives of many individuals suffering from this condition.

Latest Patents

Sakamoto holds a patent for a depression treatment agent that contains N-acetyl-D-mannosamine. This invention provides a pharmaceutical composition for treating depression, which includes an effective amount of N-acetyl-D-mannosamine along with a carrier that is acceptable as a medicament. This patent highlights his commitment to advancing medical science and providing new solutions for mental health issues. He has 1 patent to his name.

Career Highlights

Yasuharu Sakamoto is affiliated with the University of Tokyo, where he conducts research and develops innovative solutions in the field of pharmaceuticals. His work is characterized by a strong focus on addressing complex health challenges through scientific research and innovation.

Collaborations

Sakamoto has collaborated with esteemed colleagues, including Hideharu Seto and Koji Hayakawa. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatment options.

Conclusion

Yasuharu Sakamoto's contributions to the field of depression treatment exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in pharmaceutical research and offers hope for those affected by depression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…